Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ·Healthcare·Biotechnology
$12.28
+4.60%
Mkt Cap $1.00B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (13 analysts)
$33.17
Range $27.00 – $42.00
Implied Upside
+170.1%
Consensus $33.17 vs current $12.28
NASDAQ·Healthcare·Biotechnology
$12.28
+4.60%
Mkt Cap $1.00B
Buy
5
Hold
0
Sell
0
Price Target (13 analysts)
$33.17
Range $27.00 – $42.00
+170.1%
Consensus $33.17 vs current $12.28